View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Modigene Inc

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP

2009 JAN 26 ... Modigene Inc. (OTC Bulletin Board: MODG) reported results from a pilot toxicity study in primates ...

Subject: Hormones

Price: $3.00

Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

2009 FEB 9 ... Modigene Inc. (OTC Bulletin Board: MODG) reported that its Israeli-based R&D subsidiary has received ...

Subject: Hormones

Price: $3.00

Modigene Sets Record Date for Annual Meeting of Shareholders

2009 FEB 25 ... Modigene Inc. (OTC Bulletin Board: MODG) announced that its board of directors has set the close of ...

Subject: Modigene Inc.

Price: $3.00

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

2009 JUN 23 ... Modigene Inc. (OTC Bulletin Board: MODG) announced that shareholders approved a proposal to change ...

Subject: Prolor Biotech, Inc.

Price: $3.00

Modigene to Present at the BIO-Europe Spring(R) 2009 Conference

2009 MAR 23 ... Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company developing a long-acting human ...

Subject: Modigene Inc.

Price: $3.00

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of the Frost Group

2009 AUG 3 ... PROLOR Biotech, Inc. (BULLETIN BOARD: PBTH) , formerly Modigene Inc., announced that it has entered into stock purchase agreements with private investors to ...

Subject: Prolor Biotech, Inc.

Price: $3.00

PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone

2009 OCT 5 ... PROLOR Biotech, Inc. (BULLETIN BOARD: PBTH) formerly Modigene Inc., announced the initiation of a Phase I clinical trial of its long-acting human growth ...

Subject: Hormones

Price: $3.00

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

2009 JUL 13 ... PROLOR Biotech, Inc. (BULLETIN BOARD: PBTH) , formerly Modigene Inc., announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents ...

Subject: Women's Health

Price: $3.00

PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference

2009 SEP 28 ... PROLOR Biotech, Inc. (BULLETIN BOARD: PBTH) formerly Modigene Inc., announced that President Shai Novik will present at the upcoming UBS Global Life ...

Subject: Prolor Biotech, Inc.

Price: $3.00

Modigene Announces Appointment of Dr. Phillip Frost as Chairman of Its Board of Directors

2008 MAR 17 ... Modigene Inc. (BULLETIN BOARD: MODG) announced the appointment of Phillip Frost, M.D., as Chairman of ...

Subject: Biotechnology

Price: $3.00

Modigene Announces Closing of $12 Million Financing by Members of the Frost Group

2008 APR 7 ... Modigene Inc. (BULLETIN BOARD: MODG) , a biopharmaceutical company applying its patented technology ...

Subject: Biopharmaceuticals

Price: $3.00

Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Human Growth Hormone

2007 DEC 10 ... Modigene Inc. (BULLETIN BOARD: MODG) reported that its Israeli-based R&D subsidiary has received ...

Subject: Hormones

Price: $3.00

Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta

2008 AUG 18 ... Modigene Inc. (BULLETIN BOARD: MODG) reported that its Israeli-based R&D subsidiary has received ...

Subject: Pre-Trials Research

Price: $3.00

Modigene Inc. provides information on its latest news and research developments

2007 OCT 9 ... Modigene Inc. provides information on its latest news and research developments. This ...

Subject: Modigene Inc.

Price: $3.00

Modigene Platform Validated in Independent Phase III Trial of CTP Technology

2008 JUL 21 ... Modigene Inc., (BULLETIN BOARD: MODG) today noted the successful completion of a Phase III clinical ...

Subject: Women's Health

Price: $3.00

Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

2007 NOV 12 ... Modigene Inc. (BULLETIN BOARD: MODG) announced that senior management will present at the Acumen ...

Subject: Modigene Inc.

Price: $3.00

New activities and developments reported by Modigene Inc.

2007 SEP 18 ... New activities and developments reported by Modigene Inc.. This trend article is an immediate alert from NewsRx to identify the ...

Subject: Modigene Inc.

Price: $3.00

NIMS Elects Dr. Jane H. Hsiao Chairman of the Board

2008 NOV 17 ... Inc. (OTCBB:SFES), a position she has held since September 2007, and as a director of Modigene, Inc. (OTCBB:MODG), a developmental stage biopharmaceutical company and Neovasc, Inc. ...

Subject: Non-Invasive Monitoring Systems, Inc.

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx